BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Côté I, Sakarya Y, Kirichenko N, Morgan D, Carter CS, Tümer N, Scarpace PJ. Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction. Can J Physiol Pharmacol 2017;95:206-14. [PMID: 28051332 DOI: 10.1139/cjpp-2016-0290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Goit RK, Taylor AW, Yin Lo AC. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174956] [Reference Citation Analysis]
2 Côté I, Green SM, Morgan D, Carter CS, Tümer N, Scarpace PJ. Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction. Can J Physiol Pharmacol 2018;96:308-12. [PMID: 29131966 DOI: 10.1139/cjpp-2017-0440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Baldini G, Phelan KD. The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol 2019;241:R1-R33. [PMID: 30812013 DOI: 10.1530/JOE-18-0596] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 13.3] [Reference Citation Analysis]